The European Investment Bank (EIB) is presenting the InnovFin Infectious Diseases Finance Facility (IDFF), its financial product dedicated to supporting the fight against infectious diseases, at the 28th European Congress of Clinical Microbiology and Infectious Diseases.

The congress gathers the world’s leading experts in the topic around a variety of meeting formats including keynote lectures, symposia, presentations and educational session.

The EIB will present IDFF at the Pipeline Corner, a platform, where small innovative pharmaceutical companies with early-stage antimicrobial therapies in development are able to present their products to a wider audience.

IDFF provides financing for amounts typically between EUR 7.5 million and EUR 75 million to innovative players active in developing innovative vaccines, drugs, medical and diagnostic devices or novel research infrastructures for combatting infectious diseases. Read more about InnovFin IDFF.

‘InnovFin Infectious Diseases’ is a financial instrument of ‘InnovFin – EU Finance for Innovators’, a joint European Commission and EIB Group initiative falling under Horizon2020, the 2014-2020 EU research and innovation programme.